MedPageToday -- BOSTON -- Extended follow-up of a landmark HIV prevention study is “reassuring,” the lead researcher said here. The prevention tool -- a single two-drug anti-HIV pill once a day -- had a durable effect, was safe, and did not lead to drug resistance, according to Robert Grant, MD, of the University of California San Francisco.
